Home
About
Overview
Sharing Data
ORCID
Help
History (2)
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
Preparation of DNA containing 5-hydroxymethyl-2'-deoxycytidine modification through phosphoramidites with TBDMS as 5-hydroxymethyl protecting group.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer. Cancer Chemother Pharmacol. 1999; 44(1):81-7.
View in:
PubMed
subject areas
Antineoplastic Agents
Apoptosis
Cell Cycle
Cell Division
Cell Line
Cisplatin
Combined Modality Therapy
Drug Resistance, Multiple
Flavonoids
Genes, Tumor Suppressor
Humans
Piperidines
Radiotherapy
Tumor Cells, Cultured
Urinary Bladder Neoplasms
Urothelium
authors with profiles
Walter M. Stadler
Carrie W. Rinker-Schaeffer